busulfan has been researched along with Viral Hepatitis, Human in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The conditioning regimen was cyclophosphamide (160 mg/kg) and busulfan (10-14 mg/kg), followed by unmanipulated bone marrow (median of 5&10(8) cells/kg) and CyA (+MTX in two patients) for prophylaxis of graft-versus-host disease (GvHD)." | 5.09 | Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. ( Bacigalupo, A; Benvenuto, F; Berisso, G; Bregante, S; Figari, O; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Van Lint, MT, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raiola, AM | 1 |
| Van Lint, MT | 1 |
| Lamparelli, T | 1 |
| Gualandi, F | 1 |
| Benvenuto, F | 1 |
| Figari, O | 1 |
| Mordini, N | 1 |
| Berisso, G | 1 |
| Bregante, S | 1 |
| Frassoni, F | 1 |
| Bacigalupo, A | 1 |
1 trial available for busulfan and Viral Hepatitis, Human
| Article | Year |
|---|---|
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft Sur | 2000 |